VPCIR Biosciences
VPCIR Biosciences is a spin-out from Aarhus University, Denmark, with 20 years of development in technology capable of detecting living pathogens in saliva. The company is focused on developing faster, cheaper, and non-invasive diagnostic tests, starting with tuberculosis and expanding to other infectious diseases, using innovative lateral flow tests and proprietary technology.
Industries
Nr. of Employees
small (1-50)
Products
Saliva-based lateral flow tuberculosis test (planned availability 2025)
A point-of-care lateral flow test designed to detect active tuberculosis from saliva using enzyme-activity based sensing, intended to be non-invasive and low-cost for field use.
Rolling circle amplification activity kit (research/assay kit)
A laboratory kit/workflow demonstrating RCA-based detection of topoisomerase and other enzyme activities in biological samples for research and assay development.
DNA sensor platform for viral integrase and retrovirus detection
A DNA sensor approach that translates integrase-mediated integration events into RCA templates for highly sensitive detection and discrimination of retroviruses.
Saliva-based lateral flow tuberculosis test (planned availability 2025)
A point-of-care lateral flow test designed to detect active tuberculosis from saliva using enzyme-activity based sensing, intended to be non-invasive and low-cost for field use.
Rolling circle amplification activity kit (research/assay kit)
A laboratory kit/workflow demonstrating RCA-based detection of topoisomerase and other enzyme activities in biological samples for research and assay development.
DNA sensor platform for viral integrase and retrovirus detection
A DNA sensor approach that translates integrase-mediated integration events into RCA templates for highly sensitive detection and discrimination of retroviruses.
Services
Clinical evaluation and field trial support
Protocol development and on-site execution of field trials comparing enzyme-activity diagnostics to reference molecular tests and monitoring treatment response.
Assay development and adaptation for low-resource settings
Design and optimization of enzyme-activity based assays with pump-free microfluidic extraction and visual/colorimetric outputs for point-of-care use.
Regulatory and quality management system consulting for IVDs
Support for developing QMS and processes aligned with ISO 13485 and IVDR requirements to prepare diagnostics for CE marking and market entry.
Clinical evaluation and field trial support
Protocol development and on-site execution of field trials comparing enzyme-activity diagnostics to reference molecular tests and monitoring treatment response.
Assay development and adaptation for low-resource settings
Design and optimization of enzyme-activity based assays with pump-free microfluidic extraction and visual/colorimetric outputs for point-of-care use.
Regulatory and quality management system consulting for IVDs
Support for developing QMS and processes aligned with ISO 13485 and IVDR requirements to prepare diagnostics for CE marking and market entry.
Expertise Areas
- Enzyme-activity based diagnostics
- Point-of-care lateral flow diagnostics
- Saliva-based infectious disease testing
- Rolling circle amplification assay development
Key Technologies
- Rolling circle amplification (RCA)
- Lateral flow assays
- Droplet microfluidics
- Molecular beacons (fluorometric probes)